Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou

(Pages: 155-165)
Yuping Li, M.D, 1,#Yaser Tahamtani, Ph.D, 2,3,#Mehdi Totonchi, Ph.D, 3,4,#Chengshui Chen, M.D, 1,#Seyed Mohammad Reza Hashemian, M.D., 5Fatemeh Amoozegar, B.Sc., 6Jin-San Zhang, Ph.D., 1,7,*Yousef Gholampour, M.D., 8,*Xiaokun Li, Ph.D., 1,9,*
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China
Department of Diabetes, Obesity and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Noncommunicable diseases research center, Fasa University of Medical Sciences, Fasa, Iran
International Collaborative Center on Growth Factor Research, and School of Pharmaceutical Sciences, Wenzhou Medical University, China
Department of Internal Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
School of Pharmaceutical Sciences, Wenzhou Medical University, and Wenzhou Biomedicine Collaborative Innovation Center, Wenzhou, China
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, China
Department of Diabetes, Obesity and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Noncommunicable diseases research center, Fasa University of Medical Sciences, Fasa, Iran
International Collaborative Center on Growth Factor Research, and School of Pharmaceutical Sciences, Wenzhou Medical University, China
Department of Internal Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
School of Pharmaceutical Sciences, Wenzhou Medical University, and Wenzhou Biomedicine Collaborative Innovation Center, Wenzhou, China
*Corresponding Addresses: Department of Pulmonary and Critical Care Medicine The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 China. Department of Internal Medicine School of Medicine Fasa University of Medical Sciences Fasa Iran. School of Pharmaceutical Sciences Wenzhou Medical University and Wenzhou Biomedicine Collaborative Innovation Center Wenzhou 325035 China Emails:Zhang_JinSan@wmu.edu.cn,Y.gholampoor@fums.ac.ir,Xiaokunli@wmu.edu.cn

These authors contributed equally to this work.

Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Li Yuping, Tahamtani Yaser, Totonchi Mehdi, Chen Chengshui, Hashemian Seyed Mohammad Reza, Amoozegar Fatemeh, Zhang Jin-San, Gholampour Yousef, Li Xiaokun. Challenges of Iranian Clinicians in Dealing with COVID-19: Taking Advantages of The Experiences in Wenzhou. Cell J. 2020; 22(): 155-165.

Abstract

The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.